Amgen sees no bone safety concerns around experimental obesity drug
Amgen sees no bone safety concerns around experimental obesity drug Source link
Amgen sees no bone safety concerns around experimental obesity drug Source link
Federal Reserve chair Jerome Powell speaks during a news conference on Sept.18, 2024 in Washington, DC. Anna Moneymaker | Getty The U.S. Federal Reserve could carry out fewer interest rate cuts than previously expected next year should President-elect Donald Trump’s proposed global tariffs take hold, former Fed policymaker Loretta Mester said Tuesday. Mester indicated that the Fed’s outlook was set to change under the incoming Republican administration’s fiscal plans, and